Geode Capital Management’s Nautilus Biotechnolgy NAUT Stock Holding History
Bought
Maintained
Sold
Other funds holding NAUT
ACM
PA
CM
VCM
CA
CFM
ACI
ST
Geode Capital Management's NAUT Position: Q1 2026 in Review
Geode Capital Management increased its Nautilus Biotechnolgy (NAUT) stake by 7.6% in Q1 2026, buying an estimated $105K and bringing the position to 603,524 shares worth $2.34M. The position accounts for ﹤0.01% of the portfolio, ranked #3066.
Geode Capital Management first reported a position in NAUT in Q2 2021 and has held it in 20 quarters since. The position peaked at $3.9M in Q2 2023. 81 funds tracked by Wall St. Rank hold NAUT as of Q1 2026.
- Geode Capital Management held 603,524 shares of Nautilus Biotechnolgy worth $2.34M as of Q1 2026.
- Geode Capital Management bought 42,615 Nautilus Biotechnolgy shares in Q1 2026, an estimated $105K.
- Nautilus Biotechnolgy made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #3066 holding.
- Geode Capital Management first reported a position in Nautilus Biotechnolgy in Q2 2021 and has held it in 20 quarters since.
- Geode Capital Management's Nautilus Biotechnolgy position peaked at $3.9M in Q2 2023.
- 81 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q1 2026.
Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.